ARGX
argenx SEstockNASDAQADR
At CloseNov 13, 2026 3:59:55 PM EST
959.78USD-2.196%(-21.55)225,894
After-hoursNov 13, 2026 4:00:30 PM EST
960.04USD+0.027%(+0.26)
Loading…
Loading…
60.32B
Healthcare
Biotechnology
CEO
Tim Van Hauwermeiren
HQ
Amsterdam, Noord Brabant, Netherlands
843
Previous Close
$981.33
Beta
0.53
52-Week High
$1,072.75 2026-09-02
52-Week Low
$661.85 2026-03-20
SMA 50
$925.75
SMA 200
$859.72
Avg. Vol 10D
419,329
Avg. Vol 30D
473,603
Avg. Vol 90D
344,436
Relative Vol
0.48
62.89M
59.28M
94.27%
1,412,594
2.30%
3.42
52%/48%
73.24%
58.66%
0.4100%
100,000
555
429
-907.4M
-877.7M
ARGX Profile
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
ARGX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 927.21 | 2026-11-06 | +3.46% | 0.928 |
| 1M | 802.64 | 2026-10-13 | +19.51% | 1.207 |
| 3M | 856.94 | 2026-08-13 | +11.94% | 0.964 |
| 6M | 802.70 | 2026-05-13 | +19.50% | 0.382 |
| 1Y | 891.73 | 2025-11-13 | +7.57% | 0.530 |
| 2Y | 599.35 | 2024-11-13 | +60.05% | — |
| 5Y | 309.64 | 2021-11-12 | +209.80% | 0.609 |
ARGX Stock Summary
argenx SE (NASDAQ:ARGX) stock price today is $959.27, and today's volume is 225,894. ARGX is down 2.248% today. The 30 day average volume is 473,603. ARGX market cap is $60.32B with 62.89M shares outstanding.
